BackLotus Pharmaceutical , Ltd. Overview

Lotus Pharmaceutical , Ltd. Intangible Assets

Latest intangible assets for 1795.TW: $27B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$26.67B
↑ 181.31% YoYΔ $17.19B vs prior year quarter

Peer trimmed avg / median

Loading

Lotus Pharmaceutical , Ltd. Intangible Assets History

Loading

Lotus Pharmaceutical , Ltd. vs. peers: Intangible Assets Comparison

Loading

Lotus Pharmaceutical , Ltd. Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lotus Pharmaceutical , Ltd. (1795.TW) FAQ

As of the most recent data (June 2026), 1795.TW shows a intangible assets of $27B. That compares with $9.5B in the prior-year period — up 181.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1795.TW's intangible assets is now $27B (was $9.5B) — a 181.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lotus Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 1795.TW's intangible assets over time shows whether Lotus Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $27B That compares with $9.5B in the prior-year period — up 181.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Lotus Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $27B) with ownership activity and broader fundamentals.